ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 30 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $168,000 | -34.4% | 284,285 | 0.0% | 0.01% | -25.0% |
Q3 2021 | $256,000 | -30.8% | 284,285 | 0.0% | 0.01% | -33.3% |
Q2 2021 | $370,000 | -6.3% | 284,285 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $395,000 | +8.5% | 284,285 | 0.0% | 0.01% | -7.7% |
Q4 2020 | $364,000 | -13.5% | 284,285 | 0.0% | 0.01% | -31.6% |
Q3 2020 | $421,000 | -6.2% | 284,285 | 0.0% | 0.02% | -17.4% |
Q2 2020 | $449,000 | +63.9% | 284,285 | 0.0% | 0.02% | 0.0% |
Q1 2020 | $274,000 | -85.7% | 284,285 | -41.6% | 0.02% | -59.6% |
Q3 2019 | $1,919,000 | -40.2% | 486,978 | -38.3% | 0.06% | -6.6% |
Q2 2019 | $3,211,000 | -68.7% | 788,958 | -46.1% | 0.06% | -73.1% |
Q1 2019 | $10,272,000 | +6.6% | 1,463,208 | -17.2% | 0.23% | -11.3% |
Q4 2018 | $9,636,000 | -49.3% | 1,768,104 | -0.0% | 0.26% | -7.9% |
Q3 2018 | $18,994,000 | -16.2% | 1,768,568 | +1.7% | 0.28% | -21.7% |
Q2 2018 | $22,670,000 | +48.7% | 1,739,805 | +18.8% | 0.36% | +14.5% |
Q1 2018 | $15,241,000 | +15.0% | 1,463,894 | -0.0% | 0.31% | -1.3% |
Q4 2017 | $13,255,000 | – | 1,464,204 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,790,964 | $11,359,000 | 18.32% |
Deer VII & Co. Ltd. | 2,263,365 | $9,212,000 | 8.07% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $13,555,000 | 3.47% |
Partner Investment Management, L.P. | 287,851 | $1,172,000 | 1.24% |
SPHERA FUNDS MANAGEMENT LTD. | 491,193 | $1,999,000 | 0.27% |
PFM Health Sciences, LP | 788,958 | $3,211,000 | 0.06% |
Perceptive Advisors | 132,300 | $538,000 | 0.01% |
Fosun International Ltd | 29,877 | $124,000 | 0.01% |
WEDBUSH SECURITIES INC | 15,400 | $63,000 | 0.01% |
Paloma Partners Management Co | 52,100 | $212,000 | 0.00% |